Acumen Pharmaceuticals In... (ABOS)
NASDAQ: ABOS
· Real-Time Price · USD
1.42
0.02 (1.43%)
At close: Aug 15, 2025, 3:59 PM
1.45
2.11%
After-hours: Aug 15, 2025, 07:52 PM EDT
Acumen Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 178K | n/a | n/a | n/a | 290K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 45K | 89K | 45K | 45K | 44K | 39K | 40K | 53K | 52K | 49K | 44K | 39K | 37K | 3K | 1K | 2.25M | 2.53M |
Gross Profit | n/a | -45K | 89K | -45K | -45K | -44K | -39K | -40K | -53K | -52K | -49K | -44K | -39K | -37K | -3K | -1K | -2.25M | -2.53M |
Operating Income | -41.75M | -30.37M | -39.6M | -32.27M | -24.38M | -17.77M | -18.49M | -16.04M | -13.48M | -13.13M | -14.25M | -11.37M | -10.41M | -9.21M | -8.41M | -3.94M | -3.44M | -3.79M |
Interest Income | 2.02M | 2.47M | 2.99M | 3.5M | 3.82M | 4M | 3.95M | 3.12M | 1.88M | 1.83M | 1.39M | 663K | 260K | 76K | 39K | 37K | 4K | 4K |
Pretax Income | -40.95M | -28.8M | -37.15M | -29.77M | -20.54M | -14.87M | -16.5M | -12.96M | -11.61M | -11.31M | -12.87M | -10.71M | -10.15M | -9.13M | -8.35M | -3.9M | -61.36M | -27M |
Net Income | -40.95M | -28.8M | -37.15M | -29.77M | -20.54M | -14.87M | -16.5M | -12.96M | -11.61M | -9.48M | -13.86M | -10.05M | -9.89M | -9.05M | -8.35M | -3.9M | -61.36M | -27M |
Selling & General & Admin | 4.63M | 5.1M | 5.03M | 5.02M | 4.85M | 5.33M | 5.19M | 4.86M | 4.34M | 4.42M | 3.5M | 3.06M | 3.09M | 3.22M | 2.74M | 2.13M | 1.19M | 1.22M |
Research & Development | 37.13M | 25.27M | 34.57M | 27.25M | 19.53M | 12.45M | 13.29M | 11.18M | 9.13M | 8.71M | 10.75M | 8.31M | 7.32M | 5.99M | 5.67M | 1.8M | 2.25M | 2.58M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -39K | n/a | -16K | -4K | -10K | -2K | n/a | 1K | 4K | 19K | 19K | 9K |
Operating Expenses | 41.75M | 30.37M | 39.6M | 32.27M | 24.38M | 17.77M | 18.45M | 16.04M | 13.48M | 13.13M | 14.25M | 11.37M | 10.41M | 9.21M | 8.41M | 3.94M | 3.44M | 3.79M |
Interest Expense | 1.05M | 1.02M | 1.04M | 1.03M | 1M | 1M | 581K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 23K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 41.75M | 30.37M | 39.6M | 32.27M | 24.38M | 17.77M | 18.49M | 16.04M | 13.48M | 13.13M | 14.25M | 11.37M | 10.41M | 9.21M | 8.41M | 3.94M | 3.44M | 3.79M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -44K | n/a | -40K | n/a | -1.83M | 998K | -661K | -260K | -77K | -66K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 60.57M | 60.53M | 60.01M | 60.08M | 60.08M | 59.81M | 57.91M | 54.23M | 41.03M | 41.03M | 40.86M | 40.5M | 40.5M | 40.47M | 38.27M | 38.27M | 38.65M | 36.99M |
Shares Outstanding (Diluted) | 60.57M | 60.53M | 60.01M | 60.08M | 60.08M | 59.81M | 58.01M | 54.23M | 41.03M | 41.03M | 40.86M | 40.5M | 40.5M | 40.47M | 38.27M | 38.27M | 38.65M | 36.99M |
EPS (Basic) | -0.68 | -0.48 | -0.62 | -0.5 | -0.34 | -0.25 | -0.28 | -0.24 | -0.28 | -0.23 | -0.34 | -0.25 | -0.24 | -0.22 | -0.22 | -0.1 | -1.59 | -0.73 |
EPS (Diluted) | -0.68 | -0.48 | -0.62 | -0.5 | -0.34 | -0.25 | -0.28 | -0.24 | -0.28 | -0.23 | -0.34 | -0.25 | -0.24 | -0.22 | -0.22 | -0.1 | -1.59 | -0.73 |
EBITDA | -41.75M | -27.73M | -36.07M | -28.69M | -19.49M | -13.83M | -15.88M | -16.04M | -11.56M | -11.26M | -14.24M | -11.37M | -10.41M | -9.17M | -8.37M | -3.94M | -3.44M | -3.79M |
EBIT | -39.9M | -27.77M | -36.12M | -28.74M | -19.53M | -13.87M | -15.92M | -16.04M | -11.61M | -11.31M | -14.25M | -11.37M | -10.41M | -9.21M | 72.65M | -3.94M | -3.44M | -3.79M |
Depreciation & Amortization | n/a | 45K | 44K | 45K | 45K | 44K | 39K | 40K | 53K | 52K | 49K | 44K | 39K | 37K | 3K | 1K | 3.44M | 3.79M |